Impairment of HLA Class I-Restricted Associated with Antigen Processing Results in Protein BNLF2a to the Transporter Specific Targeting of the EBV Lytic Phase

[1]  R. Tampé,et al.  The Varicellovirus UL49.5 Protein Blocks the Transporter Associated with Antigen Processing (TAP) by Inhibiting Essential Conformational Transitions in the 6+6 Transmembrane TAP Core Complex1 , 2008, The Journal of Immunology.

[2]  R. Tampé,et al.  Signaling of a Varicelloviral Factor across the Endoplasmic Reticulum Membrane Induces Destruction of the Peptide-loading Complex and Immune Evasion* , 2008, Journal of Biological Chemistry.

[3]  R. Tampé,et al.  Varicellovirus UL49.5 Proteins Differentially Affect the Function of the Transporter Associated with Antigen Processing, TAP , 2008, PLoS pathogens.

[4]  R. Tampé,et al.  The Varicellovirus UL 49 . 5 Protein Blocks the Transporter Associated with Antigen Processing ( TAP ) by Inhibiting Essential Conformational Transitions in the 6 6 Transmembrane TAP Core Complex 1 , 2008 .

[5]  M. Ressing,et al.  TAP-inhibiting proteins US6, ICP47 and UL49.5 differentially affect minor and major histocompatibility antigen-specific recognition by cytotoxic T lymphocytes. , 2007, International immunology.

[6]  M. Ressing,et al.  A CD8+ T cell immune evasion protein specific to Epstein-Barr virus and its close relatives in Old World primates , 2007, The Journal of experimental medicine.

[7]  M. Preuss,et al.  Redox regulation of peptide receptivity of major histocompatibility complex class I molecules by ERp57 and tapasin , 2007, Nature Immunology.

[8]  P. Cresswell,et al.  Selective loading of high-affinity peptides onto major histocompatibility complex class I molecules by the tapasin-ERp57 heterodimer , 2007, Nature Immunology.

[9]  K. Knoops,et al.  An infectious recombinant equine arteritis virus expressing green fluorescent protein from its replicase gene. , 2007, The Journal of general virology.

[10]  K. Bieńkowska-Szewczyk,et al.  Bovine Herpesvirus 1 UL49.5 Protein Inhibits the Transporter Associated with Antigen Processing despite Complex Formation with Glycoprotein M , 2006, Journal of Virology.

[11]  F. Momburg,et al.  Physical and Functional Interactions of the Cytomegalovirus US6 Glycoprotein with the Transporter Associated with Antigen Processing* , 2006, Journal of Biological Chemistry.

[12]  E. Kieff,et al.  Virus and Cell RNAs Expressed during Epstein-Barr Virus Replication , 2006, Journal of Virology.

[13]  P. Lehner,et al.  Downregulation of cell surface receptors by the K3 family of viral and cellular ubiquitin E3 ligases , 2005, Immunological reviews.

[14]  H. Ploegh,et al.  Viral modulation of antigen presentation: manipulation of cellular targets in the ER and beyond , 2005, Immunological reviews.

[15]  M. Ressing,et al.  Impaired Transporter Associated with Antigen Processing-Dependent Peptide Transport during Productive EBV Infection1 , 2005, The Journal of Immunology.

[16]  R. Tampé,et al.  Varicelloviruses avoid T cell recognition by UL49.5-mediated inactivation of the transporter associated with antigen processing. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[17]  P. Lehner,et al.  Viral degradation of the MHC class I peptide loading complex. , 2004, Immunity.

[18]  K. Früh,et al.  Human cytomegalovirus inhibits tapasin-dependent peptide loading and optimization of the MHC class I peptide cargo for immune evasion. , 2004, Immunity.

[19]  P. Cresswell,et al.  Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids , 2004, Immunogenetics.

[20]  H. Ploegh,et al.  The ER‐Lumenal Domain of the HHV‐7 Immunoevasin U21 Directs Class I MHC Molecules to Lysosomes , 2003, Traffic.

[21]  R. Øvstebø,et al.  PCR-based calibration curves for studies of quantitative gene expression in human monocytes: development and evaluation. , 2003, Clinical chemistry.

[22]  H. Virgin,et al.  Virus subversion of the MHC class I peptide-loading complex. , 2003, Immunity.

[23]  J. Yewdell,et al.  Viral interference with antigen presentation , 2002, Nature Immunology.

[24]  E. Wiertz,et al.  Viral immune evasion: a masterpiece of evolution , 2002, Immunogenetics.

[25]  L. Lybarger,et al.  Physical Association of the K3 Protein of Gamma-2 Herpesvirus 68 with Major Histocompatibility Complex Class I Molecules with Impaired Peptide and β2-Microglobulin Assembly , 2002, Journal of Virology.

[26]  H. Heslop,et al.  Treatment of Epstein-Barr virus-associated malignancies with specific T cells. , 2002, Advances in cancer research.

[27]  R. Tampé,et al.  Molecular Mechanism and Structural Aspects of Transporter Associated with Antigen Processing Inhibition by the Cytomegalovirus Protein US6* , 2001, The Journal of Biological Chemistry.

[28]  H. Ploegh,et al.  A Human Herpesvirus 7 Glycoprotein, U21, Diverts Major Histocompatibility Complex Class I Molecules to Lysosomes , 2001, Journal of Virology.

[29]  R. Tampé,et al.  Immune escape of melanoma: first evidence of structural alterations in two distinct components of the MHC class I antigen processing pathway. , 2001, Cancer research.

[30]  P. Stevenson,et al.  MHC class I ubiquitination by a viral PHD/LAP finger protein. , 2001, Immunity.

[31]  P. Cresswell,et al.  Distinct functions and cooperative interaction of the subunits of the transporter associated with antigen processing (TAP) , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[32]  P. Lehner,et al.  The human cytomegalovirus gene product US6 inhibits ATP binding by TAP , 2001, The EMBO journal.

[33]  P. Lehner,et al.  Inhibition of MHC class I-restricted antigen presentation by gamma 2-herpesviruses. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[34]  D. Ganem,et al.  Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[35]  W. Hammerschmidt,et al.  The Epstein–Barr virus lytic program is controlled by the co‐operative functions of two transactivators , 2000, The EMBO journal.

[36]  Jae U. Jung,et al.  Downregulation of Major Histocompatibility Complex Class I Molecules by Kaposi's Sarcoma-Associated Herpesvirus K3 and K5 Proteins , 2000, Journal of Virology.

[37]  J. Neefjes,et al.  The major substrates for TAP in vivo are derived from newly synthesized proteins , 2000, Nature.

[38]  P. A. Peterson,et al.  Human Cytomegalovirus Immediate Early Glycoprotein US3 Retains MHC Class I Molecules by Transient Association , 2000, Traffic.

[39]  Structure of the active domain of the herpes simplex virus protein ICP47 in water/sodium dodecyl sulfate solution determined by nuclear magnetic resonance spectroscopy. , 1999, Biochemistry.

[40]  A. Plebani,et al.  HLA class I deficiencies due to mutations in subunit 1 of the peptide transporter TAP1. , 1999, The Journal of clinical investigation.

[41]  U. Koszinowski,et al.  A cytomegalovirus glycoprotein re‐routes MHC class I complexes to lysosomes for degradation , 1999, The EMBO journal.

[42]  J. C. Cross,et al.  Elucidation of the genetic basis of the antigen presentation defects in the mutant cell line .220 reveals polymorphism and alternative splicing of the tapasin gene , 1998, European journal of immunology.

[43]  M. Androlewicz,et al.  Herpes Simplex Virus Inhibitor ICP47 Destabilizes the Transporter Associated with Antigen Processing (TAP) Heterodimer* , 1998, The Journal of Biological Chemistry.

[44]  P. Cresswell,et al.  Soluble tapasin restores MHC class I expression and function in the tapasin-negative cell line .220. , 1998, Immunity.

[45]  J. Trowsdale,et al.  HLA-DO is a negative modulator of HLA-DM-mediated MHC class II peptide loading , 1997, Current Biology.

[46]  R. Tampé,et al.  The active domain of the herpes simplex virus protein ICP47: a potent inhibitor of the transporter associated with antigen processing. , 1997, Journal of molecular biology.

[47]  P. Cresswell,et al.  The human cytomegalovirus US6 glycoprotein inhibits transporter associated with antigen processing-dependent peptide translocation. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[48]  R. F. Cook,et al.  The Active Site of ICP47, a Herpes Simplex Virus–encoded Inhibitor of the Major Histocompatibility Complex (MHC)-encoded Peptide Transporter Associated with Antigen Processing (TAP), Maps to the NH2-terminal 35 Residues , 1997, The Journal of experimental medicine.

[49]  P. A. Peterson,et al.  The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP. , 1997, Immunity.

[50]  U. Koszinowski,et al.  A viral ER-resident glycoprotein inactivates the MHC-encoded peptide transporter. , 1997, Immunity.

[51]  R. Tampé,et al.  Structure of the viral TAP-inhibitor ICP47 induced by membrane association. , 1997, Biochemistry.

[52]  H. Ploegh,et al.  Viruses use stealth technology to escape from the host immune system. , 1997, Molecular medicine today.

[53]  U. Koszinowski,et al.  A mouse cytomegalovirus glycoprotein retains MHC class I complexes in the ERGIC/cis-Golgi compartments. , 1997, Immunity.

[54]  T. Rapoport,et al.  Sec6l-mediated transfer of a membrane protein from the endoplasmic reticulum to the proteasome for destruction , 1996, Nature.

[55]  P. Cresswell,et al.  Roles for calreticulin and a novel glycoprotein, tapasin, in the interaction of MHC class I molecules with TAP. , 1996, Immunity.

[56]  D. Andrews,et al.  Stable binding of the herpes simplex virus ICP47 protein to the peptide binding site of TAP. , 1996, The EMBO journal.

[57]  P. A. Peterson,et al.  Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47. , 1996, The EMBO journal.

[58]  M. Bogyo,et al.  The Human Cytomegalovirus US11 Gene Product Dislocates MHC Class I Heavy Chains from the Endoplasmic Reticulum to the Cytosol , 1996, Cell.

[59]  J. Yewdell,et al.  Assembly, Intracellular Localization, and Nucleotide Binding Properties of the Human Peptide Transporters TAP1 and TAP2 Expressed by Recombinant Vaccinia Viruses (*) , 1995, The Journal of Biological Chemistry.

[60]  P. A. Peterson,et al.  A viral inhibitor of peptide transporters for antigen presentation , 1995, Nature.

[61]  J. Yewdell,et al.  Herpes simplex virus turns off the TAP to evade host immunity , 1995, Nature.

[62]  J. Salamero,et al.  Homozygous human TAP peptide transporter mutation in HLA class I deficiency. , 1994, Science.

[63]  D. Andrews,et al.  A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes , 1994, Cell.

[64]  J. Slot,et al.  Location of MHC-encoded transporters in the endoplasmic reticulum and cis-Golgi , 1992, Nature.

[65]  M. Brenner,et al.  Endoplasmic reticulum resident protein of 90 kilodaltons associates with the T- and B-cell antigen receptors and major histocompatibility complex antigens during their assembly. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[66]  R. Demars,et al.  Production of human cells expressing individual transferred HLA-A,-B,-C genes using an HLA-A,-B,-C null human cell line. , 1989, Journal of immunology.

[67]  H. Ploegh,et al.  Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. , 1986, Journal of immunology.

[68]  C. Barnstable,et al.  Production of monoclonal antibodies to group A erythrocytes, HLA and other human cell surface antigens-new tools for genetic analysis , 1978, Cell.